London South East | The UK's favourite investor portal.

6:28:50 171.85 18,725 32.18k O
16:29:45 171.85 10,000 17.18k O
16:25:04 172.00 10,000 17.20k O
10:50:56 166.706 27,347 45.59k O
12:54:06 169.85 25,500 43.31k O
08:30:57 171.662 25,950 44.55k O
08:08:28 170.00 52,246 88.82k O
12:53:28 169.351 25,544 43.26k O
08:56:55 168.35 30,000 50.51k O
17:05:58 171.50 4,900 8,404 O
16:00:28 170.650 10,000 17.07k O
15:54:40 171.85 10,000 17.18k O
15:54:01 171.80 10,000 17.18k O
15:52:32 171.75 10,000 17.18k O

03-Nov-20 15:00:30 74.00 123,000 Buy* 71.00 73.00 91.02k O
03-Nov-20 08:00:56 80.66 75,000 Buy* 71.00 73.00 60.50k O
03-Nov-20 15:20:57 74.50 50,000 Buy* 71.00 73.00 37.25k O
03-Nov-20 16:08:16 74.30 65,000 Buy* 71.00 73.00 48.30k O
03-Nov-20 09:49:05 77.00 100,000 Buy* 71.00 73.00 77.00k O
03-Nov-20 13:19:35 76.00 50,000 Buy* 71.00 73.00 38.00k O
03-Nov-20 11:55:48 74.50 78,000 Buy* 71.00 73.00 58.11k O
03-Nov-20 10:44:19 74.65 30,818 Buy* 71.00 73.00 23.01k O
03-Nov-20 15:05:47 74.02 50,000 Buy* 71.00 73.00 37.01k O
03-Nov-20 08:19:23 79.40 31,478 Buy* 71.00 73.00 24.99k O
03-Nov-20 10:46:58 74.03 30,542 Buy* 71.00 73.00 22.61k O
03-Nov-20 08:01:18 80.50 62,099 Buy* 71.00 73.00 49.99k O
03-Nov-20 09:23:43 77.00 166,000 Buy* 71.00 73.00 127.82k O
03-Nov-20 08:00:06 81.90 61,037 Buy* 71.00 73.00 49.99k O
03-Nov-20 16:30:07 73.00 263,703 Buy* 71.00 73.00 192.50k O
03-Nov-20 08:02:37 80.00 50,000 Buy* 71.00 73.00 40.00k O
03-Nov-20 09:20:55 77.534 237,000 Buy* 71.00 73.00 183.76k O
03-Nov-20 08:20:38 78.00 95,000 Buy* 71.00 73.00 74.10k O
03-Nov-20 08:00:41 81.70 61,187 Buy* 71.00 73.00 49.99k O
03-Nov-20 12:37:54 74.00 100,000 Buy* 71.00 73.00 74.00k O
03-Nov-20 09:16:34 77.60 64,420 Buy* 71.00 73.00 49.99k O
03-Nov-20 11:16:57 74.27 30,220 Buy* 71.00 73.00 22.44k O
03-Nov-20 12:37:37 75.00 253,000 Buy* 71.00 73.00 189.75k O
03-Nov-20 10:32:33 75.56 29,018 Buy* 71.00 73.00 21.93k O
03-Nov-20 08:01:00 80.50 62,099 Buy* 71.00 73.00 49.99k O
03-Nov-20 08:01:16 80.50 65,000 Buy* 71.00 73.00 52.33k O
03-Nov-20 08:05:16 80.00 65,000 Buy* 71.00 73.00 52.00k O
03-Nov-20 10:29:32 76.00 50,000 Buy* 71.00 73.00 38.00k O
03-Nov-20 08:29:16 79.90 28,777 Buy* 71.00 73.00 22.99k O
03-Nov-20 09:02:04 78.7127 106,864 Buy* 71.00 73.00 84.12k O
03-Nov-20 08:34:39 77.65 50,000 Buy* 71.00 73.00 38.83k O
03-Nov-20 08:51:07 78.151 33,000 Buy* 71.00 73.00 25.79k O
03-Nov-20 08:00:41 80.55 30,000 Buy* 71.00 73.00 24.17k O
03-Nov-20 09:56:59 77.00 45,441 Buy* 71.00 73.00 34.99k O
03-Nov-20 16:01:23 73.00 100,000 Buy* 71.00 73.00 73.00k O
03-Nov-20 08:30:26 80.00 27,803 Buy* 71.00 73.00 22.24k O
03-Nov-20 08:01:47 80.36 73,000 Buy* 71.00 73.00 58.66k O
03-Nov-20 08:34:10 78.50 135,000 Buy* 71.00 73.00 105.98k O
03-Nov-20 11:18:50 74.00 100,000 Buy* 71.00 73.00 74.00k O
03-Nov-20 12:24:42 75.40 79,568 Buy* 71.00 73.00 59.99k

Mode

https://www.finextra.com/pressarticle/84352/mode-raises-75-million-in-first-day-of-trading-on-london-stock-exchange

Mode interview

https://m.youtube.com/watch?feature=youtu.be&v=iMnbkM96w-I

End

From the 5th October

Mode is a UK-based fintech group, building a modern financial services business to support an increasingly digitised economy and financial system, combining banking, payments, investment, customer loyalty and digital assets. Its business today comprises:

· Mode app - a digital banking app that allows users to manage their traditional and digital assets all in one place.

· Bitcoin Jar - one of the highest-yielding and most flexible interest-generating accounts for Bitcoin in the market (accessible through the Mode app).

· Business payments (WeChat and Alipay) - payment processing services for UK and European businesses to tap into the Chinese market. Mode has secured key partnerships with Tencent (owner of WeChat) and Alipay.

· Business marketing services (WeChat) - marketing and social media services for UK and European businesses on one of China's most popular communication apps.

From the 20th October:

The Board of Vela is pleased to announce that it has entered into an agreement (the "Agreement") with St George Street Capital Limited ("SGS" or "St George Street"), whereby Vela has acquired an economic interest in the potential commercialisation of SGS's asset to treat individuals with diabetes who are suffering with COVID-19.

https://www.sgscapital.org/

The more you read it the better it gets!

Chairman’s final statement:

The Board is currently considering a number of investment opportunities in line with its existing investing policy and certain of these potential new investments are at an advanced stage of due diligence, documentation and/or completion. The Board anticipates a lively second half of the financial year and announcements will be made by the Company at the appropriate time.

James Normand, still has things tucked up his sleeve :-))

I feel we’ll be seeing more of these days in the near term.

NB all credit other BB members for this information.

I like VELA a lot. To me its more like a fund with all the due diligence done by James Normands' and his team who are far more informed than I could ever be. With a flow of 'new investments that are in the advance stage of due diligence, documentation and/or completion' The Board anticipates a lively second half of the financial year' . This is without any results. All looking very positive IMO .

New Investments

Mode Investment £250,000. Digital banking app cash or Bitcoin

Clinical Phase 2 Trial in Covid Diabetics £2,350,000

When you look at the fact VELA has 20% of its MCap invested in the Covid diabetes trial alone, not to mention the other high profile investments such as MODE, the Mcap already looks low. Not to mention if any of these investments take off, the upside potential is huge.

http://www.velatechplc.com/

Covid

https://www.sgscapital.org/

https://www.pharmiweb.com/pwtoday-story/first-patient-dosed-with-potential-new-therapeutic-pfor-treatment-of-covid-19-in-diabetes-sufferers

Trial detail

It also has a clean safety profile having been already in twenty-five trials for another indication in almost a thousand patients

Remember it's NOT a covid cure it's an inflammatory treatment to lessen reactions that result in oxygen and ventilators being needed in patients. It will have applications outside of Covid recovery that makes it more valuable in my eyes as it could potentially be applied to all kinds of inflammation issues in the future once this stupid virus has done one.

https://www.thetimes.co.uk/article/investors-back-potential-drug-for-diabetic-covid-19-patients-06dm759n8

Diabetics with COVID

Findings: " 23?698 in-hospital COVID-19-related deaths occurred during the study period. A third occurred in people with diabetes: 7434 (31·4%) in people with type 2 diabetes, 364 (1·5%) in those with type 1 diabetes, and 69 (0·3%) in people with other types of diabetes. "

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30272-2/fulltext#:~:text=23%20698%20in%2Dhospital%20COVID

Trial detail results due December 2020

https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002211-21/GB

https://www.diabetes.org.uk/research/take-part-in-research/arcadia-trial-treatment

https://clinicaltrials.gov/ct2/show/NCT04516759

Latest Share Chat

Member Info for MriGoat

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)